NCT00003936View on ClinicalTrials.gov

Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1999

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Lymphoma
Interventions
DRUG

bryostatin 1

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00003936 - Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease | Biotech Hunter | Biotech Hunter